Morlat P - Search Results

1

An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.

Capdepont S, Aurillac-Lavignolle V, Faure M, Dupon M, Morlat P, Ragnaud JM, Chêne G, Fleury H, Masquelier B; GECSA. Capdepont S, et al. Among authors: morlat p. J Clin Virol. 2006 May;36(1):36-42. doi: 10.1016/j.jcv.2006.01.008. Epub 2006 Feb 28. J Clin Virol. 2006. PMID: 16513416

2

Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients.

Chêne G, Angelini E, Cotte L, Lang JM, Morlat P, Rancinan C, May T, Journot V, Raffi F, Jarrousse B, Grappin M, Lepeu G, Molina JM. Chêne G, et al. Among authors: morlat p. Clin Infect Dis. 2002 Mar 1;34(5):649-57. doi: 10.1086/338811. Epub 2002 Jan 24. Clin Infect Dis. 2002. PMID: 11810598 Clinical Trial.

3

[Causes of death in HIV-infected French drug users, 1995-2000].

Lewden C, Bonnet F, Bevilacqua S, Heripret L, May T, Morlat P, Jougla E, Dabis F, Chêne G, Salmon D; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine; Groupe "Mortalité 2000". Lewden C, et al. Among authors: morlat p. Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S4-10. Ann Med Interne (Paris). 2002. PMID: 12518077 French.

4

Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measures.

Thiébaut R, Jacqmin-Gadda H, Leport C, Katlama C, Costagliola D, Le Moing V, Morlat P, Chêne G; APROCO Study Grooup. Thiébaut R, et al. Among authors: morlat p. J Biopharm Stat. 2003 May;13(2):271-82. doi: 10.1081/BIP-120019271. J Biopharm Stat. 2003. PMID: 12729394

5

Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.

Salmon-Céron D, Lassalle R, Pruvost A, Benech H, Bouvier-Alias M, Payan C, Goujard C, Bonnet E, Zoulim F, Morlat P, Sogni P, Pérusat S, Tréluyer JM, Chêne G; CORIST-ANRS HC1 Study Group. Salmon-Céron D, et al. Among authors: morlat p. Clin Infect Dis. 2003 May 15;36(10):1295-304. doi: 10.1086/374837. Epub 2003 May 9. Clin Infect Dis. 2003. PMID: 12746776 Clinical Trial.

6

Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.

Thiébaut R, Chêne G, Jacqmin-Gadda H, Morlat P, Mercié P, Dupon M, Neau D, Ramaroson H, Dabis F, Salamon R; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Thiébaut R, et al. Among authors: morlat p. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):380-6. doi: 10.1097/00126334-200307010-00013. J Acquir Immune Defic Syndr. 2003. PMID: 12843750

7

Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.

Neau D, Jouvencel AC, Legrand E, Trimoulet P, Galperine T, Chitty I, Ventura M, Le Bail B, Morlat P, Lacut JY, Ragnaud JM, Dupon M, Fleury H, Lafon ME. Neau D, et al. Among authors: morlat p. J Med Virol. 2003 Sep;71(1):41-8. doi: 10.1002/jmv.10451. J Med Virol. 2003. PMID: 12858407 Clinical Trial.

8

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P. Bonnet F, et al. Among authors: morlat p. Cancer. 2004 Jul 15;101(2):317-24. doi: 10.1002/cncr.20354. Cancer. 2004. PMID: 15241829 Free article.

9

Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.

Duval X, Journot V, Leport C, Chêne G, Dupon M, Cuzin L, May T, Morlat P, Waldner A, Salamon R, Raffi F; Antiprotease Cohort (APROCO) Study Group. Duval X, et al. Among authors: morlat p. Clin Infect Dis. 2004 Jul 15;39(2):248-55. doi: 10.1086/422141. Epub 2004 Jul 1. Clin Infect Dis. 2004. PMID: 15307035

10

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G; Mortality 2000 study group. Lewden C, et al. Among authors: morlat p. Int J Epidemiol. 2005 Feb;34(1):121-30. doi: 10.1093/ije/dyh307. Epub 2004 Nov 23. Int J Epidemiol. 2005. PMID: 15561752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters